Allakos Inc.
General ticker "ALLK" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $67.0M (TTM average)
Allakos Inc. follows the US Stock Market performance with the rate: 5.0%.
Estimated limits based on current volatility of 0.3%: low 0.33$, high 0.33$
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.80$, 2.50$]
- 2025-12-31 to 2026-12-31 estimated range: [1.15$, 3.16$]
Financial Metrics affecting the ALLK estimates:
- Negative: Non-GAAP EPS, $ of -1.01 <= 0.04
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -48.65 <= 1.79
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Industry earnings per price (median), % of -27.42 <= 0
Short-term ALLK quotes
Long-term ALLK plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $322.43MM | $196.06MM | $122.22MM |
| Operating Income | $-322.43MM | $-196.06MM | $-122.22MM |
| Non-Operating Income | $2.48MM | $10.36MM | $6.41MM |
| R&D Expense | $265.08MM | $150.91MM | $72.22MM |
| Income(Loss) | $-319.95MM | $-185.70MM | $-115.82MM |
| Profit(Loss)* | $-317.48MM | $-185.70MM | $-115.82MM |
| Stockholders Equity | $310.43MM | $168.82MM | $78.82MM |
| Assets | $386.42MM | $243.61MM | $96.60MM |
| Operating Cash Flow | $-279.97MM | $-116.48MM | $-93.62MM |
| Capital expenditure | $8.33MM | $0.59MM | $0.12MM |
| Investing Cash Flow | $71.68MM | $93.17MM | $44.76MM |
| Financing Cash Flow | $141.88MM | $2.53MM | $0.18MM |
| Earnings Per Share** | $-5.02 | $-2.14 | $-1.30 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.